About us

HAEMATO — Well Established

HAEMATO and all its employees are primarily oriented towards the needs of patients and customers in their daily work. Service, quality and reliability are essential elements of our customer orientation and at the same time drivers of further growth.

We will be happy to answer any questions or specific concerns you may have.

Ordering Service Germany

Phone 030 / 677 9867 – 600
Fax 030 / 677 9867 – 707

Ordering Service Austria

Phone 0800 / 293 527
Fax 0800 / 296 426

4,200 m² total area at the Site in Schönefeld

More than 7,000 customers

152 employees

28 apprentices since foundation

67 % female employees

For more than15 years, HAEMATO has been committed to actively help reduce costs in the healthcare system so that every patient can benefit from the latest therapies and treatment options, even if these are often very expensive.

With our product portfolio of off-patent and patent-protected pharmaceuticals, we contribute to an efficient supply of medicines, reducing costs for health insurance companies and thus for patients.

In the area of our own brands, the focus is on development, acquisition, licensing and distribution of prescription drugs and OTC products, special cosmetics as well as dietary supplements in the lifestyle and aesthetics sector.

Products and services of the medical-aesthetic market are increasingly in demand. Society, which is getting older and staying fit longer, wants to look their perceived age. Also due to the increased social acceptance of beauty medicine, the beauty market is a growing branch within the health market.

News

Find out about the current business development of HAEMATO AG as well as about our investor relations activities.

To the news archive

Investor News

With the current omicron wave, laboratories in Germany are facing a sharp increase in PCR testing. The evaluation capacities are pushing increasingly towards their limits, especially with regards to the new quarantine regulations.

In operational terms, HAEMATO AG is heading for a record year following the acquisition of M1 Aesthetics GmbH. In addition, the expansion of their private label business is increasingly coming into focus. In this regard, the company plans to expand its portfolio with a botulinum toxin product under its own brand. GBC analyst Cosmin Filker spoke …

interim report

Investor News

HAEMATO continues to grow: consolidated revenue in the third quarter of 2021 increased by 9% year-over-year to EUR 65.1 million. From 1 January to 30 September 2021, consolidated revenue rose to 216.6 million euros. This corresponds to a growth of 23 % compared to the same period of the previous year. Group EBIT increased to 1.4 million euros in …

Always there for you

Ordering Service Germany

Phone 030 / 677 9867 – 600
Fax 030 / 677 9867 – 707

Ordering Service Austria

Phone 0800 / 293 527
Fax 0800 / 296 426